Cyclo Therapeutics, Inc. Warrant
CYTHW
CYTHW was delisted on the 25th of March, 2025.
2 hedge funds and large institutions have $1.21K invested in Cyclo Therapeutics, Inc. Warrant in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
51% less capital invested
Capital invested by funds: $2.48K → $1.21K (-$1.27K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$108 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$19 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $1.19K | +$108 | +800 | +7% |
|
|
2
Bank of America
Charlotte,
North Carolina
| $19 | +$19 | +144 | New |
|
CYTHW Hedge Fund Activity: Q3 2024 in Review
2 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q3 2024, worth a combined $1.21K — down 51% from $2.48K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CYTHW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $108.
- 2 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q3 2024, up from 1 in Q2 2024.
- Funds reported $1.21K of Cyclo Therapeutics, Inc. Warrant stock for Q3 2024, down 51% quarter-over-quarter.
- 1 fund opened new Cyclo Therapeutics, Inc. Warrant positions in Q3 2024 and 0 closed out, a net change of +1 holder.
- The largest Cyclo Therapeutics, Inc. Warrant buyer in Q3 2024 was Citadel Advisors, an estimated $108 added.
Based on aggregated 13F filings for Q3 2024.